评估MENA地区的仿制药的定价和补偿政策,以提高效率,可负担性和仿制药透率
Bregtje W Kamphuis1, Panos Kanavos1
1Department of Health Policy, Medical Technology Research Group - LSE Health, London School of Economics and Political Science, UK.
Health policy OPEN
|June 29, 2023
概括
中东和北非 (MENA) 国家可以通过对仿制药的供给侧和需求侧政策进行实施来提高医疗保健的效率. 由于对仿制药的不信任,需要采用整体方法.
科学领域:
- 卫生政策 卫生政策
- 制药经济学 制药经济学
- 医疗保健管理的管理
背景情况:
- 中东和北非 (MENA) 的医疗保健系统面临着资金和交付方面的挑战.
- 增加仿制药的使用增加了宏观经济效率和财务可持续性.
- 仿制药对于具有成本效益的医疗保健服务至关重要.
研究的目的:
- 批判性地评估11个中东和北非国家的仿制药的供需侧政策.
- 确定该地区当前仿制药政策的关键特征和有效性.
- 为优化仿制药利用提供建议.
主要方法:
- 使用初级和二级证据的分析框架.
- 审查供给侧政策:定价,报销和采购.
- 对需求侧政策的评估:通用处方和替代条款.
主要成果:
- 价格上限和外部参考定价 (ERP) 是共同的定价政策.
- 招标是补偿和采购的主要方法.
- 需求侧政策 (处方,替代) 通常不存在或非强制性.
- 中东和北非国家主要专注于供给侧成本降低.
结论:
- 中东和北非国家有机会为提高效率和成本效益量身定制通用政策.
- 由于地区对仿制药的不信任,仅供给侧政策可能是不够的.
- 为中东和北非国家推一项整体战略,将供给侧和需求侧政策结合起来.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
782
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
782
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
191
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
191
Factors Influencing Drug Absorption: Pharmaceutical Parameters
157
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
157
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K


